Third Rock Ventures

Latest statistics and disclosures from Third Rock Ventures's latest quarterly 13F-HR filing:

Portfolio Holdings for Third Rock Ventures

Third Rock Ventures holds 5 positions in its portfolio as reported in the September 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Global Blood Therapeutics In 58.1 $622M NEW 15M 42.16
 View chart
Sage Therapeutics (SAGE) 25.5 $273M -26% 6.4M 42.32
 View chart
Blueprint Medicines (BPMC) 14.7 $158M 7.4M 21.34
 View chart
Eleven Biotherapeutics 1.1 $12M 4.8M 2.41
 View chart
Zafgen 0.6 $6.7M -93% 210k 31.95
 View chart

Past Filings by Third Rock Ventures

SEC 13F filings are viewable for Third Rock Ventures going back to 2013